Lobo José Luís, Zorrilla Vanesa, Aizpuru Felipe, Uresandi Fernando, Garcia-Bragado Ferrán, Conget Francisco, Monreal Manuel
Servicio de Neumología, Unidad de Investigación, Hospital de Txagorritxu, Vitoria, Spain.
Chest. 2006 Dec;130(6):1817-22. doi: 10.1378/chest.130.6.1817.
The influence of the clinical syndromes of pulmonary embolism (PE) on clinical outcome has not been evaluated.
The Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) is an ongoing registry of consecutive patients with acute venous thromboembolism. In this study, all enrolled patients with acute PE without preexisting cardiac or pulmonary disease were classified into three clinical syndromes: pulmonary infarction, isolated dyspnea, or circulatory collapse. Their clinical characteristics, laboratory findings, and 3-month outcomes were compared.
As of January 2005, 4,145 patients with acute, symptomatic, objectively confirmed PE have been enrolled in RIETE. Of them, 3,391 patients (82%) had no chronic lung disease or heart failure: 1,709 patients (50%) had pulmonary infarction, 1,083 patients (32%) had isolated dyspnea, and 599 patients (18%) had circulatory collapse. Overall, 149 patients (4.4%) died during the first 15 days of therapy: 2.5% with pulmonary infarction, 6.2% with isolated dyspnea (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.7 to 3.8), and 6.5% with circulatory collapse (OR, 2.7; 95% CI, 1.7 to 4.2). From days 16 to 90, 31 patients had recurrent PE; 5 of 14 patients (36%) with pulmonary infarction died of their new PE, compared with 5 of 10 patients (50%) with isolated dyspnea, and all 7 patients (100%) with circulatory collapse.
PE patients with pulmonary infarction (50% of the whole series) had a significantly lower mortality rate both during initial therapy and after discharge.
肺栓塞(PE)的临床综合征对临床结局的影响尚未得到评估。
血栓栓塞性疾病信息登记库(RIETE)是一个正在进行的关于急性静脉血栓栓塞连续患者的登记库。在本研究中,所有纳入的无既往心脏或肺部疾病的急性PE患者被分为三种临床综合征:肺梗死、单纯呼吸困难或循环衰竭。比较了他们的临床特征、实验室检查结果和3个月的结局。
截至2005年1月,4145例急性、有症状、经客观证实的PE患者被纳入RIETE。其中,3391例患者(82%)无慢性肺部疾病或心力衰竭:1709例患者(50%)有肺梗死,1083例患者(32%)有单纯呼吸困难,599例患者(18%)有循环衰竭。总体而言,149例患者(4.4%)在治疗的前15天内死亡:肺梗死患者为2.5%,单纯呼吸困难患者为6.2%(优势比[OR],2.6;95%置信区间[CI],1.7至3.8),循环衰竭患者为6.5%(OR,2.7;95%CI,1.7至4.2)。从第16天到第90天,31例患者发生复发性PE;14例肺梗死患者中有5例(36%)死于新发PE,而10例单纯呼吸困难患者中有5例(50%),7例循环衰竭患者全部(100%)死亡。
肺梗死的PE患者(占整个系列的50%)在初始治疗期间和出院后的死亡率均显著较低。